Combining Buspirone and Escitalopram for Anxiety and Depression

Safety and Efficacy

The American College of Physicians found that augmenting SSRIs with buspirone showed similar efficacy to other augmentation strategies, with no difference in serious adverse events, in patients with depression and anxiety 1
Augmentation of citalopram with buspirone was comparable to bupropion augmentation in terms of response and remission rates, with discontinuation due to adverse events higher with buspirone (20.6%) compared to bupropion (12.5%), in the STAR*D trial 1

The most critical period for monitoring serotonin syndrome is the first 24-48 hours after starting the combination or increasing doses, according to clinical guidelines 2
Starting buspirone at 5 mg twice daily when adding to existing escitalopram therapy, and titrating gradually up to a maximum of 20 mg three times daily if needed, is recommended 2

Buspirone offers significant safety advantages over benzodiazepines, including no tolerance, no addiction potential, no cognitive impairment, and no paradoxical agitation, making it suitable for long-term use 2
This combination targets both depression and anxiety, making it useful for patients with comorbid anxiety and depression, with buspirone requiring 2-4 weeks to reach full therapeutic effect 2